Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

MAVENCLAD 10 mg tablets

Active Ingredient:
cladribine
Company:  
Merck See contact details
ATC code: 
L04AA40
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

MAVENCLAD 10 mg Tablets (cladribine) - Patient Guide

MAVENCLAD 10 mg Tablets (cladribine) - Patient Guide - Important information on minimising the risk of adverse events
{pdf_link}

MAVENCLAD 10 mg Tablets (cladribine) - Prescriber's Guide

{healthcare_pro_orange} For Healthcare Professionals
MAVENCLAD 10 mg Tablets (cladribine) - Prescriber's Guide - Important information on minimising the risk of adverse events

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Merck
Company image
Address
Merck Serono Ltd, 5 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA, UK
Medical Information Direct Line
+44 (0)208 818 7373
Telephone
+44 (0)208 818 7200
Fax
+44 (0)208 818 7267
Medical Information Fax
+44 (0)208 818 7274
Medical Information e-mail
[email protected]